AndhraNews.net
Home » International News » 2015 » November » November 23, 2015

Portea Medical Acquires MedybizPharma to Accelerate Penetration into India's Chronic Disease Market


November 23, 2015 - Bangalore, Karnataka, India

Business Wire India
Portea Medical, India’s largest home healthcare company, today announced that it has acquired specialty pharmaceutical distributor MedybizPharma in a move that will enable Portea to strengthen patient engagement and provide better care for chronic disease patients in India.
 
The acquisition was made for an undisclosed consideration of cash and stock.

MedybizPharma, which started in 2009, is India’s leading Pharmacy Benefits Manager (PBM). Over the last six years it has served more than two (2) lakh patients providing prescription refill and therapy compliance support for super-speciality medicines.

Portea Medical handles 60,000+ home visits a month across 24 cities in India and in September 2015 received Series B funding of $US 37.5 million from Accel, IFC, Qualcomm Ventures and Ventureast.
 
Announcing the acquisition Meena Ganesh, MD & CEO, Portea Medical said: “A structured and integrated approach enveloping awareness, monitoring and ongoing disease management is vital to tackle the battle India faces with chronic disease. While hospital-based treatments are important, continuing care delivered to patients at home is a key prong of effective treatment. Portea is already present across several chronic disease areas and with the acquisition of Medybiz, we are adding a vital and powerful, specialized pharma arm to deliver better pharmacy care to patients with chronic conditions who have ongoing needs for medication.” 

Headquartered in Bengaluru, Medybiz has 200 employees and a footprint across 26 cities in 19 states in India. The company was acquired from the Reliance ADA Group by its Management Team in 2011. Kewal Handa, a 30-year pharmaceutical industry veteran and formerly MD of Pfizer India is the Chairman of Medybiz.

Commenting on the development, Mr. Handa said: “While diseases may respond to medicine, people respond to care, and chronic diseases in particular require specialized care over many years. We have always been committed to the best outcomes for patients and are therefore delighted with our alignment with Portea which will exponentially increase the impact we have on patients.

Medybiz’s services include Speciality Pharma Support (Patient Assistance Programs ‘PAP’) for pharmaceutical companies and Pharmacy Benefits Management (PBM) services as part of employee benefits programs. The company’s offerings run the entire gamut covering Diabetes, Cardiology, Oncology, Osteoarthritis, Osteoporosis, Rheumatoid Arthritis, Tuberculosis and Neurology, amongst others.

Portea focuses on general primary health care, post-hospitalization care, chronic disease management and allied services such as diagnostics and medical equipment on hire thereby bringing the entire gamut of healthcare services to a patient’s doorstep. The company works with hospitals, insurance companies and individuals to improve health outcomes by providing a continuity of care in the home setting through doctors, nurses, physiotherapists and nursing attendants employed by Portea. The company has 50+ hospitals as partners, and a network of referring physicians all over India.
 
Background:
About Portea Medical

Portea Medical (www.portea.com) is South Asia’s home healthcare pioneer and the largest and fastest growing provider of in-home medical care in India today with a network across 24 cities in India, and four cities in Malaysia. Portea focuses on general primary health care, post-hospitalization care, chronic disease management and allied services. The company offers home visits from doctors, nurses, nursing attendants and physiotherapists. In addition, Portea also provides collection of lab samples and medical equipment on hire, bringing the entire gamut of healthcare services to a patient’s doorstep. 

Photo Caption: A Portea nurse delivering medical care at home

Source: Business Wire India

BusinessWireIndia

Comment on this story

Share